Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | CTSL | P07711 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25845102 | 0.92 | ELANE (0.34) | ELANEKMT2AMEN1GAACTSL | |
| SCHEMBL25845099 | 0.91 | — | — | |
| SCHEMBL25845198 | 0.91 | ELANE (0.34) | ELANEKMT2AMEN1GAACTSL | |
| SCHEMBL25845111 | 0.87 | KDM4E (0.31) | — | |
| SCHEMBL25845097 | 0.86 | MAPT (0.33) | KMT2AMEN1 | |
| SCHEMBL25845066 | 0.85 | ESR1 (0.31) | KMT2AMEN1 | |
| SCHEMBL25845193 | 0.84 | ELANE (0.34) | ELANEKMT2AMEN1GAACTSL | |
| SCHEMBL25845087 | 0.83 | ELANE (0.37) | ELANEKMT2AMEN1GAACTSL | |
| SCHEMBL25845190 | 0.82 | KDM4E (0.31) | KMT2AMEN1 | |
| SCHEMBL25845065 | 0.79 | ESR1 (0.32) | ELANEKMT2AMEN1CTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230201118-A1 | PRODRUG COPOLYMERS AND POLYMERIC MICELLES THEREOF FOR THE DELIVERY OF SHORT-CHAIN FATTY ACIDS, THE PROMOTION OF GUT HEALTH, AND THE TREATMENT OF IMMUNE AND/OR INFLAMMATORY CONDITIONS AND FOOD ALLERGY | THE UNIVERSITY OF CHICAGO | 2023-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230201118-A1 | PRODRUG COPOLYMERS AND POLYMERIC MICELLES THEREOF FOR THE DELIVERY OF SHORT-CHAIN FATTY ACIDS, THE PROMOTION OF GUT HEALTH, AND THE TREATMENT OF IMMUNE AND/OR INFLAMMATORY CONDITIONS AND FOOD ALLERGY | SI, VIP, FAAH | ELANE 314/4885KMT2A 1631/4885MEN1 2190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.